• Onconetix opened a strategic bridge financing facility of up to $5 million for Realbotix, its pending acquisition target.
• $2.5 million was advanced at signing to fund growth initiatives, working capital needs.
• Facility is non-interest bearing until the share exchange closes; it is automatically cancelled and discharged at closing.
• Cash required at closing will be reduced by the principal advanced under the facility, plus an additional $500,000.
• If the share exchange is terminated, interest accrues at 12% per year from the termination date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-099524), on September 14, 2026, and is solely responsible for the information contained therein.